Sponsor:
Merus B.V.
Code:
NCT07353957
Conditions
Lung Cancer - Non Small Cell Squamous
Lung Cancer - Non Small Cell Non-Squamous
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Petosemtamab + Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-23. This information was provided to ClinicalTrials.gov by Merus B.V. on 2026-04-02.